Skip to main content

Embryo Glue: Does Hyaluronan-Enriched Transfer Medium Really Improve IVF Success?

IVF Education · November 7, 2026
ProIVF Medical Editorial Team · ProIVF Medical Advisory Board reviewed
embryo gluehyaluronanembryo transferIVF add-onsimplantation
Embryo Glue: Does Hyaluronan-Enriched Transfer Medium Really Improve IVF Success?

Embryo glue is a hyaluronan-enriched transfer medium, not a glue and not a proven success booster: a 2020 Cochrane review found a live birth risk ratio of 1.21, while a 2026 meta-analysis of 20 randomised trials found 1.14 with a confidence interval that crossed 1.0.

This guide was prepared by the ProIVF medical editorial team from peer-reviewed systematic reviews, the HFEA add-on rating and ASRM guidance, and reviewed by the ProIVF Medical Advisory Board. It is written to help you judge whether the add-on is worth paying for, not to promote it.

What is embryo glue, and what is actually in the dish?

Embryo glue is the clinic nickname for transfer medium enriched with hyaluronan (hyaluronic acid) at a functional concentration, usually 0.5 mg/mL, compared with 0.125 mg/mL or none in standard medium.

QuestionKey point
What is added?Hyaluronan, a naturally occurring polysaccharide that binds the CD44 receptor on the endometrium
Functional concentration in trials0.5 mg/mL (low or no HA is 0.125 mg/mL)
When is it used?For a short exposure while embryos wait in the dish, immediately before the catheter is loaded
Is it a drug or an injection?No; it is a culture medium additive, and it never enters your bloodstream

How is it used during transfer?

The embryologist moves the selected embryo into a drop of hyaluronan-enriched medium for a brief period, then loads it into the transfer catheter. Nothing is injected into the uterus, and the embryo is not “glued” to the lining in any mechanical sense.

Embryo glue vs PICSI: the confusion that changes the numbers

PICSI is a different add-on that selects sperm by their ability to bind hyaluronan before injection, and the largest trial of PICSI found no benefit. The two products share the word “hyaluronan”, so clinic pages and forum posts often mix their results.

“Compared with ICSI, PICSI does not significantly improve term livebirth rates. The wider use of PICSI, therefore, is not recommended at present.” — Miller et al., The Lancet, 2019 (HABSelect, 2,772 couples)

That trial reported term live birth of 27.4% with PICSI versus 25.2% with standard ICSI (odds ratio 1.12, 95% CI 0.95–1.34). If a clinic quotes PICSI data to sell embryo glue, the numbers belong to a different intervention.

Does embryo glue improve live birth rates?

The best single answer is “probably a little, but not reliably”: high-quality reviews disagree, and the newest meta-analysis is neutral.

ReviewStudies and participantsLive birth effectEvidence quality
Cochrane 2020 (Heymann et al.)26 RCTs, 6,704 participantsRR 1.21 (95% CI 1.10–1.31)Moderate
Hum Reprod 2022 (Heymann et al.)15 RCTs, 4,686 participants; autologous oocytes only benefit32% → 39%, RR 1.22 (1.11–1.34), NNT 14Moderate
JBRA 2026 (Rocha et al.)24 RCTs eligible, 20 pooled; 11 reported live birthRR 1.14 (0.99–1.31, p=0.07); sensitivity analysis RR 1.06Very low

What the Cochrane review actually found

The 2020 Cochrane review pooled 10 randomised trials covering 4,066 women and estimated that live birth rises from an assumed 33% to somewhere between 37% and 44% with functional hyaluronan. Clinical pregnancy also rose (RR 1.16, 95% CI 1.09–1.23), and multiple pregnancy rose more sharply (RR 1.45, 95% CI 1.24–1.70) — a signal that deserves attention before you add the product to a double-embryo transfer.

Why donor-egg cycles behave differently

The 2022 meta-analysis separated autologous from donor-oocyte cycles for the first time. In autologous cycles the absolute gain was about 7 percentage points, with a number needed to treat of 14, while donor cycles showed no clear effect (RR 1.12, 95% CI 0.86–1.44).

The authors suggested that good-quality donor oocytes may leave little room for a medium effect to show.

What changed in 2026

The 2026 meta-analysis included 2,026 versus 2,037 participants across 11 trials and counted 803 versus 697 live births. The pooled risk ratio of 1.14 missed significance (p=0.07), the clinical pregnancy advantage disappeared in the sensitivity analysis (RR 1.05, p=0.53), and the authors rated the overall certainty as very low because most trials carried a high risk of bias.

Why do the studies disagree?

They disagree because the trials differ in who was treated, how many embryos were transferred, and how much the outcome depends on luck — and because small positive trials are more likely to be published.

Small trials and publication bias

A broader review of 188 randomised trials around embryo transfer found significant publication bias across the field (Egger’s test, p=0.001). That matters here: an add-on with a true effect near zero will still generate several positive trials, and those are the ones clinics quote.

Multiple embryos blur the signal

When two embryos are transferred, the chance of at least one implanting rises for reasons unrelated to the medium, and the extra implantation can look like a benefit of the add-on. The Cochrane multiple-pregnancy signal (RR 1.45) is the visible trace of this problem.

What the UK regulator concluded

The Human Fertilisation and Embryology Authority reviewed the same literature and did not endorse the product.

“For most fertility patients the use of hyaluronate enriched pre-transfer culture medium is rated amber because, on balance, it is not clear whether this add-on is effective at improving the treatment outcome.” — HFEA treatment add-ons rating, accessed 2026

Amber means conflicting moderate-to-high quality evidence: some studies show benefit, others do not. It is not a safety warning, and it is not a green light either.

Who is most likely to benefit?

If embryo glue helps anyone, the best case is a single-embryo transfer using your own eggs, with a well-graded blastocyst and a lining that is already adequate.

Autologous oocytes, single embryo transfer

The subgroup with the most consistent signal is autologous-oocyte transfer, where the 2022 review found an NNT of 14. The same review argued that combining the medium with a single-embryo-transfer policy could raise pregnancy rates without raising twin rates.

Recurrent implantation failure

There is no large dedicated trial in recurrent implantation failure, so the add-on is usually offered on a “why not” basis. A 2026 network meta-analysis of 36 interventions for repeated failure ranked many add-ons, but the certainty for hyaluronan remained low, so it cannot be sold as a proven rescue.

What embryo glue cannot fix

It cannot change embryo chromosomal status, correct a thin or out-of-phase lining, or replace transfer technique. Ultrasound-guided transfer, for comparison, carried a clinical pregnancy risk ratio of 1.265 (95% CI 1.151–1.391) across 24 trials — a larger and better-established effect than anything shown for the medium.

What should you ask before paying for it?

Ask for the product name, the concentration, the price, and the clinic’s own outcome data, because “embryo glue” is a nickname rather than a regulated treatment.

  • Which product and what concentration? Functional studies use 0.5 mg/mL; a lower concentration has not shown the same effect.
  • Is the fee separate from the cycle price? Ask for it in writing before the cycle starts.
  • How many embryos will be transferred? The benefit signal is strongest with a single embryo; adding the medium to a double transfer mainly raises the twin risk.
  • What is your clinic’s live birth rate for my age group? A 7-percentage-point average gain is small next to the 20–30-point spread between clinics.
  • Will it change the laboratory protocol? Some labs use hyaluronan routinely, which means you may already be receiving it without a separate charge.
  • What happens if the cycle fails? Ask whether the add-on is refunded, and get the answer in writing.

Three patients, three decisions

The three accounts below are anonymised composites based on patient-reported experiences; names, amounts and some clinical details have been changed.

”It was 2,000 yuan — I would pay again, but I know it proved nothing”

A 36-year-old in Shanghai added the medium to her second frozen transfer after a failed first cycle. Her clinic charged about 2,000 yuan (roughly US$280) for the add-on, on top of a cycle that cost her about 45,000 yuan; the transfer produced a live birth, and she describes the decision as “cheap enough that I stopped arguing”.

Her own summary is honest: “One transfer proves nothing — I paid for peace of mind, not for a guarantee."

"I asked for the trial data and the clinic went quiet”

A 41-year-old in London was quoted £350 (about US$445) for the add-on at a private clinic and asked which trials supported it. She received a leaflet rather than a citation, paid anyway, and had a biochemical pregnancy that did not progress; she says the money was not the issue, “the issue was being sold certainty that does not exist”.

”We transferred two embryos and got twins”

A 33-year-old in Toronto accepted the medium during a double-embryo transfer because she wanted “everything at once”. She conceived twins, delivered at 36 weeks, and now says she wishes someone had explained that the multiple-pregnancy signal (RR 1.45) was the clearest number in the literature: “Nobody told me the add-on was linked to more twins, not just more babies.”

Frequently Asked Questions (FAQ)

Q: Is embryo glue the same as PICSI?

No. Embryo glue is a medium additive, while PICSI selects sperm by hyaluronan binding; the largest PICSI trial (2,772 couples) found a term live birth rate of 27.4% versus 25.2%, which was not significant.

Q: Does embryo glue increase live birth rates?

Probably by a small amount at most. Cochrane 2020 estimated RR 1.21 from 10 trials and 4,066 women, but the 2026 meta-analysis of 11 live-birth trials found RR 1.14 (95% CI 0.99–1.31) with very low certainty.

Q: Does it increase the chance of twins?

Yes, the pooled data suggest it might. Cochrane 2020 reported a multiple-pregnancy risk ratio of 1.45 (95% CI 1.24–1.70) across 7 trials and 3,337 participants, which is why single-embryo transfer is the safer pairing.

Q: Is embryo glue safe?

No safety signal has emerged. The Cochrane review found no clear difference in total adverse events (RR 0.86, 95% CI 0.40–1.84), and the main documented downside is the cost plus the multiple-pregnancy risk.

Q: Does it help if I have repeated implantation failure?

The evidence is weak for that specific group. There is no large dedicated trial, and the 2026 network meta-analysis of 36 interventions kept hyaluronan at low certainty, so it should be described as optional rather than recommended.

Q: Does embryo glue work with donor eggs?

Probably not much. The 2022 meta-analysis found no clear effect in donor-oocyte cycles (RR 1.12, 95% CI 0.86–1.44) while autologous cycles improved from 32% to 39%.

Q: How much does the add-on cost?

Prices vary widely, but patients in our interviews reported fees of roughly US$280–450 on top of a cycle, and the fee is usually not refundable if the transfer fails.

Q: Can I just ask my clinic to use it?

Yes, if the laboratory stocks it. Ask for the product name and the 0.5 mg/mL concentration, and confirm whether it is already included in your cycle price.

How to plan your transfer

Treat embryo glue as a small, optional variable and put your effort into the variables with larger effects: embryo selection, single-embryo transfer, a lining check before progesterone, and a clinic with transparent age-stratified outcomes.

If you are comparing centres, start with our guide to choosing an IVF clinic and the national success-rate data, then read how to prepare before embryo transfer and what to expect after transfer. Patients deciding between a fresh and a frozen transfer can compare both routes in fresh vs frozen embryo transfer, and those with repeated failures may want the recurrent implantation failure guide.

To compare laboratories and clinics that publish their add-on policies, browse the ProIVF hospital directory or contact our editorial team with the specific product name your clinic uses.


Medical disclaimer: This article summarises published evidence and does not replace individual medical advice. Add-on policies differ between laboratories and countries, and your clinician should confirm whether hyaluronan-enriched medium is appropriate for your cycle.

How this article was created: The ProIVF medical editorial team reviewed the Cochrane review (2020), the 2022 and 2026 meta-analyses, the HABSelect trial and the HFEA add-on rating, then cross-checked every number against the published abstracts. The draft was reviewed by the ProIVF Medical Advisory Board before publication. Read more about ProIVF.

Last updated: 7 November 2026.

Ready to start your fertility journey?

Get a personalized plan from our medical advisors